VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Nov. 29, 2006) - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection CompanyTM, today announced that it has completed the second and final closing of its recently announced private placement. The Company increased the size of this placement to $10.02 million by issuing an additional 1,275,000 units at a price of $0.80 per unit generating additional proceeds of $1.02 million. On November 14th, 2006 the Company announced the completion of a first closing of the private placement issuing 11,250,000 for proceeds of $9.0 million after agreeing to increase the initial $8.0 million offering to meet demand.
